Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies are proposed as therapeutic and prophylactic agents against HIV‐1, but their potency and breadth are less than optimal.
Jianliang Xu +33 more
doaj +1 more source
Mechanisms and applications of camelid variable heavy-chain nanobodies against bacterial and parasitic protozoal pathogens. [PDF]
Gattan HS, Alandijany TA.
europepmc +1 more source
Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects. [PDF]
Liu G +11 more
europepmc +1 more source
Identification and characterization of Nanobodies targeting the EphA4 receptor
The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as
Joyce, P +16 more
core
Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion. [PDF]
D Sa J +13 more
europepmc +1 more source
Targeting angiogenesis: advances in the design and engineered applications of nanobodies. [PDF]
Liu Y, Li Z, Ma Y, Liu Y.
europepmc +1 more source
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses. [PDF]
Liu D +11 more
europepmc +1 more source
Correction: Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1. [PDF]
Zettl I +11 more
europepmc +1 more source
Self-Blinking Dye Restores Efficient Use of Nanobodies in Single-Molecule Localization Microscopy. [PDF]
Basak S +8 more
europepmc +1 more source

